⌘K

Home/Filings/4/0001012975-18-000025

4//SEC Filing

Enright William 4

Accession 0001012975-18-000025

CIK 0001326190other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:53 PM ET

Size

6.8 KB

Accession

0001012975-18-000025

Insider Transaction Report

Form 4

Period: 2018-01-02

Altimmune, Inc.ALT

Enright William

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock, par value $0.0001
2018-01-02$0.08/sh+183,347$14,668→ 364,511 total
Exercise/Conversion
Stock Options (option to buy)
2018-01-02−183,347→ 0 total
Exercise: $0.08From: 2017-05-04Exp: 2021-12-03→ Common Stock, par value $0.0001 (183,347 underlying)

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1

filerCIK 0001705564

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 4:53 PM ET
Size: 6.8 KB

View on SEC.gov